KR20180014467A - air freshener - Google Patents
air freshener Download PDFInfo
- Publication number
- KR20180014467A KR20180014467A KR1020160097750A KR20160097750A KR20180014467A KR 20180014467 A KR20180014467 A KR 20180014467A KR 1020160097750 A KR1020160097750 A KR 1020160097750A KR 20160097750 A KR20160097750 A KR 20160097750A KR 20180014467 A KR20180014467 A KR 20180014467A
- Authority
- KR
- South Korea
- Prior art keywords
- oil
- water
- simplex
- fragrance
- weight
- Prior art date
Links
- 239000002386 air freshener Substances 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000003921 oil Substances 0.000 claims abstract description 26
- 235000019198 oils Nutrition 0.000 claims abstract description 26
- 239000003205 fragrance Substances 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 239000002304 perfume Substances 0.000 claims abstract description 5
- 238000005507 spraying Methods 0.000 claims abstract description 5
- 229960004551 cotton seed extract Drugs 0.000 claims abstract 2
- 235000012343 cottonseed oil Nutrition 0.000 claims abstract 2
- 239000002385 cottonseed oil Substances 0.000 claims abstract 2
- 238000005194 fractionation Methods 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 15
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 11
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract description 8
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 abstract description 7
- 230000003115 biocidal effect Effects 0.000 abstract description 7
- 229960003085 meticillin Drugs 0.000 abstract description 7
- 108010059993 Vancomycin Proteins 0.000 abstract description 6
- 229960003165 vancomycin Drugs 0.000 abstract description 6
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 abstract description 6
- 241000194032 Enterococcus faecalis Species 0.000 abstract description 5
- 229940032049 enterococcus faecalis Drugs 0.000 abstract description 4
- 241000588724 Escherichia coli Species 0.000 abstract description 3
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 abstract description 3
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 235000013355 food flavoring agent Nutrition 0.000 abstract description 2
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 description 14
- 229940088710 antibiotic agent Drugs 0.000 description 12
- 239000001257 hydrogen Substances 0.000 description 8
- 229910052739 hydrogen Inorganic materials 0.000 description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- 230000002087 whitening effect Effects 0.000 description 6
- 241000192041 Micrococcus Species 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 description 5
- 241000194033 Enterococcus Species 0.000 description 4
- 241000191940 Staphylococcus Species 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 238000005868 electrolysis reaction Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- -1 phenol compound Chemical class 0.000 description 3
- 230000035943 smell Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 206010011409 Cross infection Diseases 0.000 description 2
- 241001468179 Enterococcus avium Species 0.000 description 2
- 244000299507 Gossypium hirsutum Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010050337 Cerumen impaction Diseases 0.000 description 1
- 241000723436 Chamaecyparis obtusa Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241001522957 Enterococcus casseliflavus Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 241000194030 Enterococcus gallinarum Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 241001668545 Pascopyrum Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241000721454 Pemphigus Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000238711 Pyroglyphidae Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004887 air purification Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000002939 cerumen Anatomy 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000007772 electroless plating Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229940046533 house dust mites Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000008368 mint flavor Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000002438 stress hormone Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/01—Deodorant compositions
- A61L9/013—Deodorant compositions containing animal or plant extracts, or vegetable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/14—Disinfection, sterilisation or deodorisation of air using sprayed or atomised substances including air-liquid contact processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2209/00—Aspects relating to disinfection, sterilisation or deodorisation of air
- A61L2209/20—Method-related aspects
- A61L2209/21—Use of chemical compounds for treating air or the like
- A61L2209/213—Use of electrochemically treated water, e.g. electrolysed water or water treated by electrical discharge
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Zoology (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
본 발명은 편백나무 추출물로서 편백 오일을 주성분으로 하는 분무(噴霧)용 방향제에 관한 것으로서 상세하게는 편백나무 추출물로부터 확보한 편백오일을 정제[精製, purification]한 편백정제오일과, 물을 전기분해하여 확보한 수소수에 희석시킨 편백오일을 주성분으로 하는 방향제에 관한 것이다.
상기 편백오일이 주성분인 방향제는, 메티실린 저항성 포도상구균(MRSA), 반코마이신 저항성 장구균(VRE) 또는 항생제 내성을 가지는 대장균, 폐렴간균, 살모넬라 티피뮤리움 및 엔테로코커스 패칼리스 등에 작용하여 항생제 내성 균주의 생장을 억제시킬 수 있다.
구성은 다음과 같다.
편백나무 추출물로부터 확보한 편백오일을 정제[精製, purification]한 정제편백오일과, 물로부터 확보한 수소수로 이루어지되 상기 수소수 60~98중량부[분량(分量)]과 정제편백오일 1~40중량부 성분을 혼합기에서 혼합하여 액체 형태인 분사용 방향제를 제조하여 분사용 분무기에 충전하는 구성이다.The present invention relates to a flavoring agent for spraying, which comprises a simplex oil as a main component thereof, and more particularly to a simplex oil which is purified from a simplex oil obtained from a simplex extract, The present invention relates to a perfume mainly composed of a soft white oil diluted with hydrogen peroxide.
The fragrance which is the major component of the mildew oil acts as a methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), or Escherichia coli, pneumococcal bacteria, Salmonella typhimurium and Enterococcus faecalis having antibiotic resistance, The growth can be suppressed.
The configuration is as follows.
A purified white oil obtained by purifying a cottonseed oil obtained from a cottonseed extract, and hydrogenated water obtained from water, wherein the water content is 60 to 98 parts by weight, And 40 parts by weight of the components were mixed in a mixer to prepare a fragrance-use fragrance in a liquid form and charged into the sprayer.
Description
본 발명은 편백나무 추출물로서 편백 오일을 주성분으로 하는 분무(噴霧)용 방향제에 관한 것으로서 상세하게는 편백나무 추출물로부터 확보한 편백오일을 정제[精製, purification]한 편백정제오일과, 물을 전기분해하여 확보한 수소수에 희석시킨 편백오일을 주성분으로 하는 방향제에 관한 것이다.The present invention relates to a flavoring agent for spraying, which comprises a simplex oil as a main component thereof, and more particularly to a simplex oil which is purified from a simplex oil obtained from a simplex extract, The present invention relates to a perfume mainly composed of a soft white oil diluted with hydrogen peroxide.
상기 편백오일이 주성분인 방향제는, 메티실린 저항성 포도상구균(MRSA), 반코마이신 저항성 장구균(VRE) 또는 항생제 내성을 가지는 대장균, 폐렴간균, 살모넬라 티피뮤리움 및 엔테로코커스 패칼리스 등에 작용하여 항생제 내성 균주의 생장을 억제시킬 수 있다.The fragrance which is the major component of the mildew oil acts as a methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), or Escherichia coli, pneumococcal bacteria, Salmonella typhimurium and Enterococcus faecalis having antibiotic resistance, The growth can be suppressed.
항생제는 병원균에 의한 감염증을 치료하는 약물로, 감염 증세에 뛰어난 효능을 보인다. 항생제를 자주 사용하다 보면 항생제에 내성을 가진 균주들이 살아남거나 돌연변이를 통하여 항생제에 대한 저항성을 가진 균주들이 생겨나게 되어 점점 더 항생제에 내성력이 강해진 병원균들이 생겨나게 되며 이 때문에 치료를 위하여 더 강력한 항생제를 사용하게 되는데, 결국은 어떤 강력한 항생제에도 저항할 수 있는 박테리아가 생겨나기도 하는 데이를 슈퍼박테리아라고 한다.Antibiotics are medicines for treating infections caused by pathogens, and show excellent efficacy against infection. When antibiotics are used frequently, strains that are resistant to antibiotics survive or are mutated to produce strains that are resistant to antibiotics, resulting in pathogens that are increasingly resistant to antibiotics. For this reason, more powerful antibiotics are used for treatment It is called super bacteria, which eventually leads to bacteria that can resist any powerful antibiotic.
슈퍼박테리아란 항생제의 잦은 사용에 저항할 수 있어 강력한 항생제에도 죽지 않는 박테리아를 의미하며, 1961년 영국에서 MRSA(Methicillin-Resistant Staphylococcus Aureus, 메티실린내성황색포도상구균)이, 1996년 Super bacteria is a bacteria that can resist the frequent use of antibiotics and is not killed by powerful antibiotics. In 1961, Methicillin-Resistant Staphylococcus Aureus (MRSA) (methicillin-resistant Staphylococcus aureus)
일본에서는 VRSA(Vancomycin-Resistant Staphylococcus Aureus, 반코마이신내성황색포도상구균)이 처음으로 보고 되었다.In Japan, VRSA (Vancomycin-Resistant Staphylococcus Aureus, vancomycin-resistant Staphylococcus aureus) was first reported.
MRSA[methicillin resistant staphylococcus aureus]는 메티실린 내성 황색포도상구균이라고 한다. 병원 감염의 주범으로서 항생제를 많이 사용하는 대형 종합병원에서 발견되는데, 공기 중이나 의사ㆍ간호사의 신체 부위, 메스, 병원 담요, 튜브 등 의료기구에 붙어 3시간 가량 사는 등 생존능력과 번식력이 강하다. 호흡기 계통과 수술 환자의 환부에 침투해 고열과 오한, 혈압 저하 등의 증상을 일으킨다.MRSA [methicillin resistant staphylococcus aureus] is called methicillin resistant Staphylococcus aureus. It is found in a large general hospital which uses antibiotics as a main cause of hospital infection. It has a strong survival ability and fertility such as a body part of the air, a doctor, a nurse, a scalpel, a hospital blanket, It infiltrates into the respiratory system and the affected part of the operation patient, causing symptoms such as high fever, chills and low blood pressure.
스메그마균[Mycobaxterium smegmatis]은 비병원성(非病原性)인 항산균(抗酸菌). 외음부점막표변, 치구(恥垢)에 상재(常在)하고 있는 균인데, 겨드랑이, 귀지, 피부의 때 흙, 물 등에도 존재하고 있다. 가늘고 긴 간균(桿菌)으로서 분기(分岐)나 다형태성(多形態性)을 보인다 결핵균과 비슷하므로 특히 요(尿)에서 검출된 경우에는 감별이 필요하다.Mycobaxterium smegmatis is a non-pathogenic acid-fast bacillus. It is a fungus that resides in the vulvar mucosal surface, jiggle, and is also present in the armpit, earwax, skin of soil, and water. It is a thin and long bacterium. It has branching and polymorphism. It is similar to mycobacteria, so it needs to be distinguished especially in urine.
미구균[Micrococcus , 微球菌]이란 호기성, 그람양성의 구상세균의1속(屬). 카탈라아제 양성, 당에서 산화적으로 산을 생성한다. 노란색, 주황색 등의 카로티노이드색소를 생성한다. 비교적 높은 염농도의 환경에서 생육하며 건조에도 잘 견딘다. 토양, 하수, 식품, 공기 등으로 분리하여 자연계에 널리 분포하고 있다. 유연속에는 Staphylococcus가 있고, Micrococcus와 Staphylococcus와의 감별에는 OF(oxidation-fermentation) 시험법을 사용한다. 즉, Micrococcus는 당을 산화적으로 분해하지만Staphylococcus는 발효적으로 분해하며 Micrococcus의Micrococcus [micrococcus] is a genus of aerobic, gram-positive, spherical bacteria. Catalase-positive, producing acid oxidatively in sugars. Yellow, orange, etc. carotenoid pigments are produced. It grows in a relatively high salt concentration environment and is resistant to drying. Soil, sewage, food, air and so on. Staphylococcus is present in the sputum, and the oxidation-fermentation (OF) test is used for the differentiation between Micrococcus and Staphylococcus. In other words, Micrococcus oxidatively degrades sugars, but Staphylococcus decomposes fermentatively, and Micrococcus
DNA의염기조성은 66~75% 사이에 분포하고 있지만 Staphylococcus의 DNA의 염기조성은 30~40% 사이에 분포하고있다. 기준종은 Micrococcus luteus이다.The base composition of DNA is distributed between 66 ~ 75%, but the base composition of Staphylococcus DNA is distributed between 30 ~ 40%. The standard species is Micrococcus luteus.
반코마이신 내성 장알균 감염 (vancomycin-resistant enterococci infection)이란 장알균 속(genus)은 그람 양성(그람 염색했을 때 짙은 보라색으로 관찰)인 알균(구균)으로, 쌍알균 또는 짧은 사슬의 형태를 하고 있다. 혈액이 들어 있지 않은 배지에서도 잘 자란다.Vancomycin-resistant enterococci infection is a type of germ-positive germ (bacterial) that is gram-positive (observed as a deep purple when stained with Gram stain) and has the form of a bacillus or short chain. It also grows well on medium without blood.
장알균은 엔테로코쿠스 파이칼리스(E. faecalis), 엔테로코쿠스 페슘(E. faecium), 엔테로코쿠스 아비움(E.avium), 엔테로코쿠스 갈리나룸(E. gallinarum), 엔테로코쿠스 카셀리플라버스(E. casseliflavus) 등 19종(species)이 알려져 있다. 인체에서 검출되는 장알균은 엔테로코쿠스 파이칼리스가 가장 흔하며, 그 다음 엔테Enterococcus is a strain of E. faecalis, E. faecium, E. avium, E. gallinarum, Enterococcus kassel, 19 species such as E. casseliflavus are known. The enterococcus pycalis is the most common intestinal bacteria detected in the human body,
로코쿠스 페슘, 엔테로코쿠스 아비움 avium) 순서이다. 엔테로코쿠스 페슘은 엔테로코쿠스 파이칼리스에 비해 항생제 내성 정도가 더 심하여 병원 감염 측면에서 더 중요하다.Rocococcus, and Enterococcus avium). Enterococcus pemphigus is more important in terms of hospital infection than antibiotic resistance in Enterococcus faecalis.
황색포도상구균은 포도상구균의 한 종류로 감염을 잘 유발하는 균이다. 이 균은 1941년 페니실린이 발명되면서 치료가 가능해졌다. 이후 페니실린이 듣지 않는 균이 출현하자 더욱 강력한 항생제인 메티실린이 개발되었지만,Staphylococcus aureus is a type of Staphylococcus aureus that causes infection. This bacterium was made possible by the invention of penicillin in 1941. After the emergence of penicillin does not listen to the more powerful antibiotic methicillin was developed,
또 다시 이 메티실린 뿐 아니라 다른 항생제도 듣지 않는 강력한 황색포도상구균이 출현하였다. 한편, 2006년 한 해 동안 미국에서 9만 4000여 명이 MRSA에 감염되어, 이 중에서 1만 9000명 이상이 사망한 것으로 알려졌다.Again, a strong Staphylococcus aureus strain, which does not listen to other antibiotics as well as methicillin, has emerged. In 2006, more than 94,000 people in the United States were infected with MRSA, of whom more than 19,000 people died.
개발된 항생제 중 가장 강력하다고 알려진 반코마이신도 1950년대 이후 균 치료에 사용되었지만 1996년 내성을 가진 VRSA가 출현하였다. VRSA는 면역력이 약해진 인체에 들어 올 경우 온갖 감염을 심화시키며, 어떤 항생제도 듣지 않아 결국 패혈증(敗血症)을 유발시켜 생명을 위협하는 초강력 세균이다. 전문가들은 VRSA가 널리 퍼질 경우 맹장염, 제왕절개 같은 간단한 수술도 마음 놓고 할 수 없을 것이라고 경고한다.Vancomycin, the most potent antibiotic developed, has been used for the treatment of bacteria since the 1950s, but VRSA with resistance has emerged in 1996. VRSA is a super-strong bacterium that threatens life because it infects all kinds of infectious diseases and does not listen to any antibiotics and eventually causes sepsis. Experts warn that if VRSA is widespread, simple surgery, such as appendicitis and caesarean section, will not be easy.
병원에는 암환자, 수술환자와 각종 감염 환자가 모여들기 때문에 이 균의 주된 감염 장소는 병원이다. 건강한 사람이라도 환자의 피부나 환자가 만진 물건과 접촉하면 옮을 수 있다. 내성률은 항생제 투여 후 세균 100마리당 살아남는 세균의 숫자로 표시하며 항생제를 많이 쓸수록 높아진다.Since the cancer is gathered in the hospital, surgical patients and various infected patients, the main infection site of the fungus is the hospital. Even a healthy person can move if the patient's skin or patient touches the object. The rate of resistance is expressed by the number of bacteria surviving per 100 bacteria after administration of antibiotics.
한편 편백나무(Chamaecyparis obtusa)는 노송나무라고도 하며, 겉씨식물 구과목 측백나무과의 상록교목으로서, 일본이 원산지이지만 개발을 통해 우리나라 남부 지방에서 조림수종으로 널리 재배되고 있는데, 편백나무 특유의 향으로 인해 탈취제, 항균제 등으로 사용되고 있다.On the other hand, Chamaecyparis obtusa, also known as cypress tree, is an evergreen tree of the ginseng plant, a Japanese plant, and is widely grown as a tree planting species in the southern part of Korea through its development, Deodorant, antibacterial agent and so on.
편백나무에서 생산되는 피톤치드는 식물의 자기방어물질로써, 병원균 및 해충, 곰팡이 등에 저항하기 위해 식물이 내뿜거나 분비하는 물질로 그 자체에 살균, 살충성분이 포함되어 있다. 피톤치드의 구성물질은 테르펜을 비롯한 페놀 화합물, 알칼로이드 성분, 글리코시드 등으로 이루어진 유기화합물이며, 항균작용, 진정작용, 탈취작용, 스트레스 해소작용 등을 하는 것으로 알려져 있다. 이러한 피톤치드는 화학합성 물질이 아닌 천연물질이고, 인간의 신체에 무리 없이 흡수되며, 인간에게 해로운 균들을 선택적으로 살균한다.Phytoncide is a self-defense substance of plants. It is a substance that plants excrete or secretes to resist pathogens, insects and fungi, and contains sterilization and insecticides. The constituent material of phytoncide is an organic compound composed of a phenol compound such as terpene, an alkaloid component, a glycoside, etc., and is known to have antimicrobial action, sedative action, deodorizing action and stress relieving action. Such phytoncide is a natural substance, not a chemical synthetic substance, and selectively absorbs bacteria which are absorbed in human body and harmful to human being.
또한, 피톤치드는 항균작용, 소취작용, 진정작용 및 스트레스 해소 작용 등 수많은 기능을 하는 것으로 알려져 있다. 또한, 피톤치드는 뛰어난 살균, 항균, 세정작용으로 피부를 깨끗하게 하고 보습작용도 하며, 체내의 면역기능을 강화한다.Phytoncide is known to have many functions such as antimicrobial action, deodorizing action, sedative action and stress relieving action. In addition, phytoncide has excellent sterilization, antibacterial and cleansing action, cleansing the skin, moisturizing and enhancing the immune function in the body.
피톤치드를 흡입할 경우, 스트레스 호르몬인 코르티졸의 농도가 획기적으로 줄어든다는 연구결과가 보고되었으며, 숲에서 동물의 사체가 썩어가도 피톤치드로 인해 악취가 심하게 발생하지 않는다고 알려져 있다. 또한, 중추신경계에 진정작용을 하여 쾌적한 느낌을 가지게 하며, 수면시간을 연장하고 편안한 숙면을 취하는데 도움을준다.It has been reported that when phytoncide is inhaled, the concentration of cortisol, which is a stress hormone, is drastically reduced, and it is known that even when the carcass of an animal rotates in the forest, the smell does not occur due to phytoncide. It also helps to calm the central nervous system and make you feel comfortable, extend your sleeping time and help you get a good night's sleep.
그리고 혈액순환계를 개선하여 고지혈증, 혈전 심부전증에도 효능이 있다고 밝혀졌으며, 인체 내에 내성이 생기지 않는 강력한 항균 작용으로도 알려졌다. 천연물질인 피톤치드는 거의 90% 까지 집먼지 진드기 기피효과를 가져와 부작용이 없으면서도 알레르기 예방에 가장 효과적인 것으로 알려져 있다.It has also been shown to improve blood circulation and to be effective in hyperlipidemia and thromboembolism, and it has also been known as a powerful antimicrobial effect that does not cause resistance in the human body. Phytoncide, a natural substance, is known to be most effective at preventing house dust mites by almost 90% without any side effects.
이처럼 편백나무에는 피톤치드는 항균력 및 공기정화 능력을 갖게 할 뿐만 아니라 스트레스가 해소되고 장과 심폐기능이 강화되며 실내의 살균작용도 가능해지는 것이어서, 최근 피톤치드의 활용에 대한 여러가지 연구가 이루어지고 있다.In this way, phytoncide has a antibacterial and air purification ability, and stress is relieved, and intestine and cardiopulmonary function are strengthened, and sterilization action of the room becomes possible. Therefore, various researches on the application of phytoncide have been conducted.
본 발명은 항균 정화 능력을 갖는 편백나무의 성분을 이용하기 위하여 편백나무로부터 추출된 편백 오일 정유성분의 메티실린 저항성 포도상구균(MRSA), 반코마이신 저항성 장구균(VRE) 또는 항생제 내성을 가지는 대장균, 폐렴간균, 살모넬라 티피뮤리움 및 엔테로코커스 패칼리스 등에 작용하여 항생제 내성 균주의 생장억제 기능을 확인함으로써 편백 오일 정유 성분을 이용한 방향제를 제공하고자 한다.(MRSA), vancomycin-resistant enterococci (VRE) or antibiotic resistant Escherichia coli, pneumococcal pneumococci (Pseudomonas aeruginosa), and the like. , Salmonella typhimurium, and Enterococcus faecalis, thereby confirming the growth-inhibiting function of antibiotic-resistant strains.
첨부한 도면에 의해 구성을 제차 살펴면, 본 발명의 편백 오일이 주성분인 분무(噴霧)용 방향제는 편백나무 추출물로부터 확보한 편백오일을 정제[精製, purification]한 정제편백오일과, It will be understood by those skilled in the art that the present invention is not limited to the above-described embodiments, but may be modified and changed without departing from the scope and spirit of the invention.
물로부터 확보한 수소수로 이루어지되 상기 수소수 60~98중량부[분량(分量)]과 정제편백오일 1~40중량부 성분 등을 혼합기에서 혼합하여 액체 형태인 분사용 방향제를 제조하여 분사용 분무기에 충전한다.And the hydrophobic fraction obtained from water is mixed with 60 to 98 parts by weight of the hydrophobic fraction and 1 to 40 parts by weight of the purified soft white oil in a mixer to prepare a liquid fragranced fragrance Charge the sprayer.
좀 더 상세하게는 용해제와 상기 수소수 80~98중량부과 정제편백오일 1~20중량부 성분 등을 혼합기에서 혼합하여 액체 형태인 분사용 방향제를 제조한다.More specifically, a solvent is mixed with a solvent, 80 to 98 parts by weight of hydrogen peroxide and 1 to 20 parts by weight of purified white oil, in a mixer to prepare a liquid fragrance.
본 발명은 편백 추출물의 제조시 구리(Cu) 성분을 첨가함으로써 기존에 제조된 제품과 상이한 성분을 가지며,미네랄 함량이 풍부하며, 피톤 치드의 주요 성분인 테르펜(terpene)류 화합물의 함량이 1~40 분량부 포함하는 특징을 가진다.The present invention relates to a method for producing an extract of cotton, comprising the steps of: adding a copper (Cu) component in the production of an albumen extract; having a different component from a previously prepared product; rich in minerals; and having a content of terpene- 40 minutes portion.
이러한 본 발명에 따른 편백 추출물은 피부 진정 효과, 알러지 완화, 바이러스 감염 차단 등의 효과를 나타내는 성분들을 함유하고 있으며, 진통, 항염 및 박하의 청량감 있는 향기, 두통 완화, 심신 안정(스트레스 해소)에 효과적이다.The present invention relates to a composition for preventing or treating skin sores, which is effective for relieving skin allergies and preventing viral infections, and is effective in relieving analgesic, anti-inflammatory and mint flavor, relieving headaches, and relieving stress to be.
따라서, 본 발명에 따른 편백 방향제는 방향제뿐만아니라 세정제, 탈취제, 방충제, 항균제, 및 가습액 등에 다양하게 이용 가능하다.Therefore, the whitening fragrance agent according to the present invention can be used not only as a fragrance but also as a detergent, a deodorant, an insect repellent, an antibacterial agent, and a humidifying liquid.
도 1은 본 발명의 편백 오일을 이용한 방향제Fig. 1 is a graph showing the results of measurement
첨부한 도면에 의해 구성을 제차 살펴보고 그에 따른 실시예를 설명하고자 한다.The present invention will now be described in detail with reference to the accompanying drawings.
본 발명의 편백 오일이 주성분인 분무(噴霧)용 방향제는 편백나무 추출물로부터 확보한 편백오일을 정제[精製, purification]한 정제편백오일(S2)과, The spraying agent for spraying of which the present invention is mainly composed of the whitening oil comprises the purified whitening oil S2 obtained by purifying the whitening oil obtained from the extract of Unplugged White,
물로부터 확보한 수소수(S1)로 이루어지되 상기 수소수 60~98중량부[분량(分量)]과 정제편백오일 1~40중량부 성분 등을 혼합기(S4)에서 혼합하여 액체 형태인 분사용 방향제를 제조하여 분사용 분무기(S5)에 충전한다.(S1), which is obtained from water, wherein 60 to 98 parts by weight of the water and 1 to 40 parts by weight of the purified white oil are mixed in a mixer (S4) A perfume is prepared and filled into the spray applicator (S5).
좀 더 상세하게는 용해제(S3)와 상기 수소수 80~98중량부과 정제편백오일 1~20중량부 성분 등을 혼합기에서 혼합하여 액체 형태인 분사용 방향제를 제조한다.More specifically, the solvent (S3) is mixed with 80 to 98 parts by weight of the hydrogen peroxide and 1 to 20 parts by weight of the purified whitening oil in a mixer to prepare a liquid fragrant perfume.
상기 용해제 [溶解劑]는 용액을 만들때에 용질을 녹이는 액체이다. The dissolver is a liquid that dissolves the solute when making the solution.
수소수는 물의 전기 분해를 이용하는 전해 방식과, 수소보다 이온화 경향이 큰 금속을 이용하는 무전해 방식으로 제조되고 있으며, 대부분의 경우에는 전해 방식으로 제조되고 있다.Hydrogen water is produced by an electrolysis method using electrolysis of water and an electroless method using a metal having a tendency to ionize more than hydrogen, and in most cases, it is manufactured by electrolysis.
먼저, 전해 방식의 경우, 전해조에 양극과 음극을 설치하고 전류를 가하면, 음극에서는 수소가 생성되고, 양극에서는 산소가 생성된다. 이때, 음극에서 생성된 수소는 물과 혼합되어 수소수로 제조되고, 양극에서 생성된 산소는 대기 중으로 방출된다. 또한, 무전해 방식의 경우, 마그네슘이나 칼슘 등과 같이 수소보다 이온화 경향이 큰 금속을 이용하는 것으로서, 이들 금속이 물과 접촉되면, 수소보다 이온화 경향이 큰 금속이 양이온으로 산화되고, 물은 OH 와 H+로 해리된다. First, in the electrolytic method, when an anode and a cathode are provided in an electrolytic cell and current is applied, hydrogen is generated in the cathode and oxygen is generated in the anode. At this time, hydrogen generated in the cathode is mixed with water to produce hydrogen water, and the oxygen generated in the anode is released into the atmosphere. In the case of electroless plating, a metal having a tendency to ionize more than hydrogen, such as magnesium or calcium, is used. When these metals are brought into contact with water, a metal having a tendency to ionize more than hydrogen is oxidized to cations. .
이때, 해리된 H+ 의 일부는 이온상태 또는 수소원자상태로 물속에 잔존되어 수소수로 제조된다.At this time, a part of dissociated H + remains in water in an ionic state or a hydrogen atom state, and is produced as a hydrogenated water.
상기 수소수는 물비린내나 염소 소독 등의 냄새가 난다. 이때, 물비린내의 경우, 수돗물 등의 원수에 함유된 철 등의 성분이 원인이 되는 것으로 알려져 있다. 또한, 수소수에는 중금속 등이 함유되어 있다. 특히, 전해 방식이나 무전해 방식으로 제조된 수소수에는 염 성분이 생성되어 함유되어 있다. 예를 들어, 전해 방식의 경우에는 치아염소산염이나 금속염 등의 염 성분이 함유되어 있다.The above-mentioned hydrogenated water smells of water smell or chlorine disinfection. In this case, it is known that in the case of watery fish, it is caused by components such as iron contained in raw water such as tap water. The hydrogenated water contains heavy metals and the like. Particularly, the electrolytic or electroless electrolytic water produced contains a salt component. For example, in the electrolytic method, salt components such as hypochlorite and metal salts are contained.
이러한 염은 카본필터 등의 필터에 수소를 통과시켜 냄새 제거 하면된다This salt can be removed by passing hydrogen through a filter such as a carbon filter
편백오일은 편백나무 잎을 저온건조기에서 건조한 다음, 건조된 편백나무 잎을 약 1 내지 3mm의 입자로 절단한다.The linseed oil is dried in a low temperature drier and then the dried linseed leaves are cut into particles of about 1 to 3 mm.
이러게 절단된 편백나무 잎을 1,000 내지 2,000메시를 통과하도록 분말화 한다The thus-cut obovate leaves are pulverized to pass 1,000 to 2,000 mesh
그 후 상기 절단된 편백나무 잎을 포집망에 넣고 증류탱크에 넣어 증류수를 공급한다.Thereafter, the cut cotton leaves are placed in a collection net and put in a distillation tank to supply distilled water.
상기 증류탱크를 가열하여 스팀을 공급하여 편백나무 잎을 통과하도록 하여 스팀에서 추출된 정유 성분이 함유된 수증기를 냉각기로 이동시켜 편백 오일과 편백수로 분리하는 단계를 통해 편백 오일을 확보할 수 있다.The distillation tank is heated to supply steam to pass through the leaved tree leaves, and the water vapor containing the essential oil component extracted from the steam is transferred to the cooler to separate the leaven oil into the leaven oil and the leaven oil. .
상기와 같은 방법에 의해 확보한 편백오일에는 다양한 불순물이 있기 때문에 그 분순물을 제거해야만 방향제로서의 제품이 완성된다.Since the monoaxial oil obtained by the above method has various impurities, it is necessary to remove the impurities to complete the product as a fragrance.
편백오일은 편백나무 잎을 저온건조기에서 건조한 다음, 건조된 편백나무 잎을 약 1 내지 3mm의 입자로 절단하는 단계; 절단된 편백나무 잎을 1,000 내지 2,000메시를 통과하도록 분말화하는 단계; 절단된 편백나무 잎을 포집망에 넣고 증류탱크에 넣어 증류수를 공급하는 단계; 증류탱크를 가열하여 스팀을 공급하여 편백나무 잎을 통과하도록 하여 스팀에서 추출된 정유 성분이 함유된 수증기를 냉각기로 이동시켜 편백 오일과 편백수로 분리하는 단계로 제조된다.The whitening oil may be obtained by drying the leaves of the perilla leaves in a low temperature drier and then cutting the dried perilla leaves into particles of about 1 to 3 mm; Pulverizing the cut whey leaves so as to pass 1,000 to 2,000 meshes; Feeding the cut wheatgrass leaves into a collection net and feeding the distilled water into a distillation tank; The distillation tank is heated to supply steam to pass through the leaved tree leaves, and the water vapor containing the essential oil component extracted from the steam is transferred to the cooler to separate the leaven oil and the white water.
S1 : 수소수 S2 : 정제편백오일
S3 : 용해제 S4 : 혼합기
S5 : 분무기S1: hydrogenated water S2: refined linseed oil
S3: Solubiliser S4: Mixer
S5: Sprayer
Claims (1)
편백나무 추출물로부터 확보한 편백오일을 정제[精製, purification]한 정제편백오일과, 물로부터 확보한 수소수로 이루어지되 상기 수소수 60~98중량부[분량(分量)]과 정제편백오일 1~40중량부 성분을 혼합기에서 혼합하여 액체 형태인 분사용 방향제를 제조하여 분사용 분무기에 충전하는 구성을 특징으로 하는 편백 오일을 이용한 방향제.In a perfume for spraying which is mainly composed of a soft white oil,
A purified white oil obtained by purifying a cottonseed oil obtained from a cottonseed extract, and hydrogenated water obtained from water, wherein the water content is 60 to 98 parts by weight, And 40 parts by weight of the components are mixed in a mixer to prepare a fragrance-use fragrance in the form of a liquid and to be charged in the sprayer for fractionation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160097750A KR20180014467A (en) | 2016-08-01 | 2016-08-01 | air freshener |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160097750A KR20180014467A (en) | 2016-08-01 | 2016-08-01 | air freshener |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20180014467A true KR20180014467A (en) | 2018-02-09 |
Family
ID=61199026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160097750A KR20180014467A (en) | 2016-08-01 | 2016-08-01 | air freshener |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20180014467A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190131157A (en) * | 2018-05-15 | 2019-11-26 | 비오신코리아 주식회사 | Oil dissolution |
CN112107713A (en) * | 2019-06-19 | 2020-12-22 | 广州龙村生物科技有限公司 | Peculiar smell remover for garbage truck |
-
2016
- 2016-08-01 KR KR1020160097750A patent/KR20180014467A/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190131157A (en) * | 2018-05-15 | 2019-11-26 | 비오신코리아 주식회사 | Oil dissolution |
CN112107713A (en) * | 2019-06-19 | 2020-12-22 | 广州龙村生物科技有限公司 | Peculiar smell remover for garbage truck |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105504966B (en) | A kind of offset litho printing ink | |
CN104873432A (en) | Hand-care disposable disinfection gel and preparation method thereof | |
KR101514524B1 (en) | Antimicrobacterial composition comprising oil from Chamaecyparis obtusa for growth inhibition of microbacteria-antimicrobial resistance | |
CN102657245A (en) | Disinfectant prepared from plant extracts as well as preparation method for disinfectant | |
CN103271985B (en) | A kind of skin mucosa disinfecting agent | |
KR20110000216A (en) | Perfume composition containing pine needle extract, mugwort extract, green tea leaf extract, and preparation method thereof | |
KR101849965B1 (en) | Injection system | |
KR20180014467A (en) | air freshener | |
Skowron et al. | Human skin microbiome: Impact of intrinsic and extrinsic factors on skin microbiota. Microorganisms 2021, 9, 543 | |
JP3849002B2 (en) | Essential oils for aromatherapy and methods of use | |
CN104381326A (en) | Anti-mold sterilization aromatic bead | |
KR20210038465A (en) | Composite for antibacterial and deodorant agent using ionized minerals and persimmon leaf extract and other natural materials | |
KR20180029345A (en) | Antimicrobial deodorization composition comprising minerals of volcanic stone extracts | |
KR102188773B1 (en) | Oil dissolution | |
CN104413075A (en) | Mould-proof agent for cupboard | |
CN103081945B (en) | A kind of mildew-eliminating and mildew-preventing agent and corresponding except mould mold-proof method | |
CN110339121A (en) | Bactericidal composition and the preparation method and application thereof | |
KR20160150332A (en) | Eco-friendly oxygen radical composition for sterilization, disinfection and deodorization comprising extracts of thymus vulgaris l. | |
CN201595180U (en) | Essential oil underwear | |
KR102249167B1 (en) | Manufacturing method for deodorant using hinoki cypress extracts and deodorant manufactured by the same | |
CN104274536A (en) | Sterilization deodorization spray for feet | |
CN104000767B (en) | A kind of Feminine care solution and preparation method thereof | |
KR20180051763A (en) | An antibacterial deodorization composition | |
KR20110045915A (en) | Sterilization and cleaning function with enhanced deodorant composition | |
CN106212542A (en) | A kind of preparation method of veterinary Chinese medicine disinfectant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20160801 |
|
PG1501 | Laying open of application | ||
PC1203 | Withdrawal of no request for examination |